Neoadjuvant chemoradiation with Gemcitabine for locally advanced pancreatic cancer

To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT).

Saved in:

Bibliographic Details
Main Authors:	Habermehl, Daniel (Author) , Eitz, Kerstin Anne (Author) , Welzel, Thomas (Author) , Hof, Holger (Author) , Abdollahi, Amir (Author) , Bergmann, Frank (Author) , Rieken, Stefan (Author) , Weitz, Jürgen (Author) , Werner, Jens (Author) , Schirmacher, Peter (Author) , Büchler, Markus W. (Author) , Debus, Jürgen (Author) , Combs, Stephanie (Author)
Format:	Article (Journal)
Language:	English
Published:	2 March 2012
In:	Radiation oncology Year: 2012, Volume: 7
ISSN:	1748-717X
DOI:	10.1186/1748-717X-7-28
Online Access:	Verlag, kostenfrei, Volltext: http://dx.doi.org/10.1186/1748-717X-7-28 Verlag, kostenfrei, Volltext: https://doi.org/10.1186/1748-717X-7-28
Author Notes:	Daniel Habermehl, Kerstin Kessel, Thomas Welzel, Holger Hof, Amir Abdollahi, Frank Bergmann, Stefan Rieken, Jürgen Weitz, Jens Werner, Peter Schirmacher, Markus W. Büchler, Jürgen Debus and Stephanie E. Combs

Description
Summary:	To evaluate efficacy and secondary resectability in patients with locally advanced pancreatic cancer (LAPC) treated with neoadjuvant chemoradiotherapy (CRT).
Item Description:	Gesehen am 11.10.2018
Physical Description:	Online Resource
ISSN:	1748-717X
DOI:	10.1186/1748-717X-7-28